Incannex Healthcare Inc. (NASDAQ: IXHL)
$2.53
-0.0200 ( -0.78% ) 27.7K
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.
Market Data
Open
$2.53
Previous close
$2.55
Volume
27.7K
Market cap
$44.64M
Day range
$2.39 - $2.67
52 week range
$0.80 - $12.68
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Quarterly Reports | 3 | Jul 26, 2023 |
| 6-k | Quarterly Reports | 3 | Jul 21, 2023 |
| 6-k | Quarterly Reports | 3 | Jul 18, 2023 |
| 6-k | Quarterly Reports | 3 | Jul 13, 2023 |
| 6-k | Quarterly Reports | 6 | Jul 10, 2023 |
| 6-k | Quarterly Reports | 3 | Jul 06, 2023 |